Combination therapy with tiotopium and indacaterol in patients with COPD

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2013
INTERVENTION: Tiotropium 18 microg and indacaterol 150 microg Indacaterol 150 microg and tiotropium 18 microg CONDITION: Chronic obstructive pulmonary disease (COPD) PRIMARY OUTCOME: Changes of values in respiratory function tests SECONDARY OUTCOME: QOL, safety INCLUSION CRITERIA: Patients with chronic obstructive pulmonary disease Patients can use the inhaled therapy Patients gave written informed consent
Epistemonikos ID: 3ce867b308939597cd8677c3ee3c2e258e3a8ecb
First added on: Aug 22, 2024